• Explore /
  • Poster
  • / Prolonged 14-day continuous infusion of high-dose ifosfamide (14IFO) for relapsed/refractory high-grade osteosarcoma (R/R HOS): A retrospective multicenter cohort study.

Prolonged 14-day continuous infusion of high-dose ifosfamide (14IFO) for relapsed/refractory high-grade osteosarcoma (R/R HOS): A retrospective multicenter cohort study.

Abstract Poster

Authors

null

Elisa Tirtei

Pediatric Onco-Hematology, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza, University of Torino, Torino, Italy

Elisa Tirtei , Veronica Sciannameo , Anna Campello , Sebastian Dorin Asaftei , Cristina Meazza , Alessandra Longhi , Angela Tamburini , Luca Coccoli , Paola Berchialla , Franca Fagioli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Bone Tumors

Clinical Trial Registration Number

NCT04651569

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11534)

DOI

10.1200/JCO.2023.41.16_suppl.11534

Abstract #

11534

Poster Bd #

468

Abstract Disclosures

Similar Posters

First Author: Maria Grazia Pionelli

First Author: Stefanie Zschaebitz

First Author: Mohammad Khurram Khan

First Author: Adriana C. Rossi